Not Yet RecruitingPhase 4ACTRN12610000289011

Does Caralluma fimbriata extract (Slimaluma) reduce the risk factors of metabolic syndrome in overweight and obese adults?

The effects of Caralluma fimbriata extract (Slimaluma) in combination with lifestyle intervention on the risk factors of metabolic syndrome in overweight and obese adults: a randomised controlled trial

Sponsor

Victoria University

Enrollment

50 participants

Start Date

May 1, 2010

Study Type

Interventional

Conditions

Prevention of metabolic syndrome

Summary

A 3-month intervention using encapsulated Caralluma fimbriata extract in combination with lifestyle intervention to investigate whether or not Caralluma fimbriata extract suppresses the appetite and decreases the risk factors of metabolic syndrome

Eligibility

Sex: Both males and femalesMin Age: 30 YearssMax Age: 60 Yearss

Plain Language Summary

Simplified for easier understanding

This study tests whether Caralluma fimbriata extract (a natural plant supplement) can help reduce risk factors associated with metabolic syndrome in overweight and obese adults aged 30 to 60. Participants must have a BMI over 25 or an elevated waist circumference.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Caralluma fimbriata extract capsule 500mg oral administration, twice per day before meals for three months. Water soluble, Caralluma fimbriata extract containing 27.8% Pregnane Glycosides and 13.3%

Caralluma fimbriata extract capsule 500mg oral administration, twice per day before meals for three months. Water soluble, Caralluma fimbriata extract containing 27.8% Pregnane Glycosides and 13.3% Saponin Glvcosides. Lifestyle intervention focuses on healthy dietary intake based on the Dietary guidelines for Australian adults for three months.

Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12610000289011